Yahoo Finance

Viral Vector Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 396 Deals Signed Since 2016 by Company A-Z, Financial terms, Deal Type and Therapy Focus

Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a ...
Yahoo Finance

Viral Vector Collaboration and Licensing Agreements Analysis Report and Directory 2016-2025: Access to Confidential Contract Documents for In-Depth Due Diligence and Benchmarking

Dublin, May 23, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...
Business Wire

4D Molecular Therapeutics and Roche Sign Collaboration Agreement for Gene Therapy Vector Discovery and Product Development

SAN FRANCISCO--(BUSINESS WIRE)--4D Molecular Therapeutics (4DMT), a leader in next-generation gene therapy vector discovery and product development, today announced a collaboration and license ...
Business Wire

Vector Laboratories and Navinci Diagnostics Announce Strategic Collaboration to Develop Novel Spatial Proteomic Tools Enabling Biomarker Discovery

NEWARK, Calif.--(BUSINESS WIRE)--Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, and Navinci Diagnostics, leader of innovative in situ proximity ligation ...
Seeking Alpha

Vector Informatik and Synopsys Announce Strategic Collaboration to Advance Software-Defined Vehicle Development

New automated cloud-ready solutions to enable customers to dramatically accelerate software development and validation. The companies are teaming up to increase the impact of the open-source library, ...
Nasdaq

4D Molecular Therapeutics Announces Collaboration on Leading Machine Learning Technology and Expertise from U.C. Berkeley to Expand Therapeutic Vector Evolution Platform

EMERYVILLE, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage gene therapy company harnessing the power of directed evolution for targeted gene ...
Mena FN

Viral Vector Collaboration And Licensing Agreements Analysis Report And Directory 2016-2025: Access To Confidential Contract Documents For In-Depth Due Diligence And Benchmarking

(MENAFN- GlobeNewsWire - Nasdaq) Viral Vector Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the viral vector deals entered into by the world's ...